Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

LON/0QQO stock hub

LON/0QQO has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0QQOis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.4B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0QQO

In the news

Latest news · LON/0QQO

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E20.4

P25 12.9P50 16.9P75 23.5

Trailing P/E21.5

P25 15.9P50 22.9P75 35.8

ROE16

P25 -54.2P50 2.1P75 13.7

ROIC11.3

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0QQO market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

237

Groups with data

Currency

CHF

Showing 237 of 237 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Switzerland
Country code	UK
Employees	3,891
Employees Change	40%
Employees Change Percent	1.03
Enterprise value	CHF 3.8B
Exchange	London Stock Exchange
Financial currency	CHF
First seen	2026-05-10
Industry	Medical - Pharmaceuticals
Isin	CH1429326825
Last refreshed	2026-05-10
Market cap	CHF 3.4B
Price	CHF 82.05
Price currency	CHF
Rev Per Employee	319,761.05x
Sector	Healthcare
Sic	2834
Symbol	lon/0QQO
Website	https://www.siegfried.ch

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.66%
EV Earnings	24.28x
EV/EBIT	18.2x
EV/EBITDA	13.19x
EV/FCF	252.08x
EV/Sales	3.06x
FCF yield	0.45%
Forward P/E	20.44x
P/B ratio	3.21x
P/E ratio	21.47x
P/S ratio	2.73x
PE Ratio10 Y	29.18x
PE Ratio3 Y	25.27x
PE Ratio5 Y	27.3x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	16.82%
EBITDA Margin	23.21%
FCF margin	1.22%
Gross margin	26.66%
Gross Profit	CHF 331.7M
Gross Profit Growth	6.46%
Gross Profit Growth Q	12.67%
Gross Profit Growth3 Y	2.14%
Gross Profit Growth5 Y	2.68%
Net Income	CHF 158M
Net Income Growth	5.37%
Net Income Growth Q	16.49%
Net Income Growth Quarters	1%
Net Income Growth Years	2%
Net Income Growth3 Y	9.26%
Net Income Growth5 Y	2.52%
Pretax Margin	15.71%
Profit Margin	12.7%
Profit Per Employee	CHF 40,615
Profitable Years	14
ROA	6.83
Roa5y	6.75
ROCE	13.71
ROE	15.98
Roe5y	16.4
ROIC	11.27
Roic5y	12.06

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	17.14%
Cagr1y	-14.64%
Cagr3y	5%
Cagr5y	0.49%
Div CAGR10	11.16%
Div CAGR3	7.48%
Div CAGR5	9.78%
EPS Growth	4.07
EPS Growth Q	15.96
EPS Growth Quarters	1
EPS Growth Years	2
EPS Growth3 Y	8.69
EPS Growth5 Y	1.97
FCF Growth	367.35%
FCF Growth3 Y	-48.11%
FCF Growth5 Y	-18.3%
OCF Growth	35.18%
OCF Growth Q	57.64%
OCF Growth10 Y	7.11%
OCF Growth3 Y	-2.84%
OCF Growth5 Y	9.51%
Revenue Growth	2.57x
Revenue Growth Q	4.99x
Revenue Growth Quarters	1x
Revenue Growth Years	11x
Revenue Growth3 Y	1.12x
Revenue Growth5 Y	1.22x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CHF 0.65
Assets	CHF 2B
Cash	CHF 97.3M
Current Assets	CHF 990.1M
Current Liabilities	CHF 495.4M
Debt	CHF 539M
Debt EBITDA	CHF 1.87
Debt Equity	CHF 0.51
Debt FCF	CHF 35.41
Equity	CHF 1.1B
Interest Coverage	31.29
Liabilities	CHF 961.4M
Long Term Assets	CHF 1B
Long Term Liabilities	CHF 466M
Net Cash	CHF -441.7M
Net Cash By Market Cap	CHF -13.02
Net Debt EBITDA	CHF 1.53
Net Debt Equity	CHF 0.42
Net Debt FCF	CHF 29.02
Tangible Book Value	CHF 995.8M
Tangible Book Value Per Share	CHF 22.73
WACC	7.48

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2
Inventory Turnover	2.45
Net Working Capital	CHF 581.1M
Quick ratio	1.14
Working Capital	CHF 491M
Working Capital Turnover	CHF 2.15

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.26%
Dividend Growth	7.41%
Dividend Growth Years	4%
Dividend per share	CHF 0.38
Dividend Years	13
Dividend Yield	0.47%
Ex Div Date	2026-04-28
Last Dividend	CHF 0.38
Payout Frequency	Annual
Payout Ratio	9.86%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	386.54%
1Y total return	-14.63%
200-day SMA	81.64
3Y total return	15.76%
50-day SMA	78.75
50-day SMA vs 200-day SMA	50under200
5Y total return	2.48%
All Time High	118.8
All Time High Change	-30.93%
All Time High Date	2024-09-16
All Time Low	13.75
All Time Low Change	496.77%
All Time Low Date	2014-10-13
ATR	2.31
Beta	0.77
Ch YTD	10.01
High	84.05
High52	101.2
High52 Date	2026-01-28
High52ch	-18.92%
Low	81.7
Low52	68.4
Low52 Date	2025-11-20
Low52ch	19.96%
Ma50ch	4.2%
Price vs 200-day SMA	0.51%
RSI	57.31
RSI Monthly	48
RSI Weekly	50.6
Sharpe ratio	-0.62x
Sortino ratio	-0.74
Total Return	-0.79%
Tr YTD	10.57
Tr1m	9.67%
Tr1w	4.46%
Tr3m	-14.36%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CHF 209.3M
Operating Income Growth	11.67
Operating Income Growth Q	21.2
Operating Income Growth3 Y	6.92
Operating Income Growth5 Y	-0.38
Operating margin	16.82

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	39,796,720%
Net Borrowing	85,082,167.2
Shares Insiders	4.04%
Shares Institutions	49.79%
Shares Qo Q	0.41%
Shares Yo Y	1.26%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CHF 7.9M
Average Volume	11,254.15x
Bv Per Share	24.13
CAPEX	CHF -198.6M
Ch10y	355.1
Ch1m	9.11
Ch1w	4.46
Ch1y	-15.06
Ch3m	-14.8
Ch3y	13.67
Ch5y	-0.23
Ch6m	10.63
Change	-2.32%
Change From Open	-1.26
Close	84
Days Gap	-1.07
Depreciation Amortization	80,075,667.8
Dollar Volume	887,288.7
Earnings Date	2026-08-21
EBIT	CHF 209.3M
EBITDA	CHF 288.7M
EPS	CHF 3.6
F Score	6
FCF	CHF 15.2M
FCF EV Yield	0.4x
Financing CF	64,172,824
Fiscal Year End	December
Founded	1,873
Graham Number	46.8751
Graham Upside	-42.87
Income Tax	CHF 37.8M
Investing CF	-216,677,334
Is Primary Listing	0
Last Earnings Date	2026-02-20
Last Report Date	2025-12-31
Last Split Date	2025-04-28
Last Split Type	Forward
Lynch Fair Value	CHF 19.11
Lynch Upside	-76.71
Ma150	79.89
Ma150ch	2.71%
Ma20	80.54
Ma20ch	1.87%
Net CF	60,273,937
Next Earnings Date	2026-08-21
Open	83.1
P FCF Ratio	222.9
P OCF Ratio	15.87
Payment Date	2026-04-30
Position In Range	14.89
Ppne	959,268,132.1
Price Date	2026-05-08
Price EBITDA	CHF 11.75
Ptbv Ratio	3.41
Relative Volume	1.01x
Revenue	1,244,190,255x
SBC By Revenue	0.59x
Share Based Comp	7,305,847
Tax By Revenue	3.03x
Tax Rate	19.31%
Tr6m	11.2%
Volume	10,814
Z Score	4.27

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

LON/0QQO dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.5%

$0.38 annual per share

Payout ratio

+9.9%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+9.8%

4 consecutive years of growth

Total shareholder yield

-0.8%

Next ex-dividend date: 2026-04-28

Performance

LON/0QQO stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0QQO?

Insider, institutional, and short-interest positioning.

Institutional ownership

+49.8%

Share of float held by funds and institutions

Insider ownership

+4.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+1.3%

Negative means the company is buying back shares.

Technical

LON/0QQO momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

57.3

Neutral momentum band

Price vs 200-day MA

+0.5%

50/200-day relationship not available

Beta (5Y)

0.77

Less volatile than the market

Sharpe ratio

-0.62

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0QQO

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0QQO stock rating?

lon/0QQO is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0QQO analysis?

The full report lives at /stocks/lon/0QQO/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0QQO?

The latest report frames lon/0QQO around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0QQO page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.